바로가기메뉴

본문 바로가기 주메뉴 바로가기
 
 

logo

  • ENGLISH
  • P-ISSN2951-0333
  • E-ISSN2951-0597

대사이상지방간질환을 동반한 자가면역간염 환자에서의 세마글루티드 사용 2례

Two Cases of Semaglutide Use in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease and Autoimmune Hepatitis

비만대사연구학술지 / Archives of Obesity and Metabolism, (P)2951-0333; (E)2951-0597
2025, v.4 no.2, pp.114-117
https://doi.org/10.23137/AOM25.04.CR0001
박정길(Jung Gil Park) (영남대학교 의과대학 내과학교실,)
최준혁(Joon Hyuk Choi) (영남대학교 의과대학 병리학교실)

Abstract

Concomitant metabolic dysfunction-associated steatotic liver disease (MASLD) and autoimmune hepatitis (AIH) complicates diagnosis, even when liver biopsy is performed. Furthermore, corticosteroid treatment can exacerbate steatosis, often impeding a complete biochemical response. As a result, assessing the histological response remains challenging, even when performing follow-up liver biopsies. Although implementing lifestyle modifications can normalize liver enzyme levels, most patients are unable to achieve adequate weight loss. In contrast, the use of semaglutide facilitated a more effective improvement in liver tests when compared to general lifestyle modifications, thereby enabling clearer assessment of liver function deterioration due to MASLD. Here, we report two cases of a diagnostic trial using semaglutide in patients with MASLD combined with AIH.

keywords
Steatohepatitis, Hepatitis, Autoimmune, Metabolic syndrome, Steroids
투고일Received
2025-11-26
수정일Revised
2025-12-16
게재확정일Accepted
2025-12-17
출판일Published
2025-12-31

비만대사연구학술지